Society for Clinical Trials Presents Blinatumomab in Childhood Standard-Risk B-Cell Acute Lymphoblastic Leukemia with Prestigious David Sackett Trial of the Year Award
Society for Clinical TrialsThe Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to 鈥淏linatumomab in Childhood Standard-Risk B-Cell Acute Lymphoblastic Leukemia.鈥